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1. Introduction
The human leukocyte antigen (HLA) system is a cluster of gene complex encoding the major 
histocompatibility complex (MHC) proteins known as antigens located on the cell mem-
brane of leukocytes in humans from which its name was derived. The functions of these cell 
surface proteins are many like responsible for the regulation of the immune system whether 
humoral or cellular in humans. It is the most important area in the vertebrate genome regard-
ing infection and autoimmunity, and is essential in adaptive and innate immunity. The HLA 
gene complex is located on a 3-Mbp stretch within short arm of chromosome number 6p21. 
HLA genes are codominantly expressed and highly polymorphic, those have many different 
alleles that modify the adaptive immune system that helps body to distinguish the body’s 
own protein from foreign invaders protein like virus, bacteria, or any other pathogens [1, 2].
1.1. Classification
The antigens of the HLA complex can be classified into three classes: class 1, class 2, and class 3.
1-MHC class I: There are three major and three minor MHC class I genes in HLA.
Major MHC class I:
• HLA-A
• HLA-B
• HLA-C
Minor MHC class I:
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• HLA-E
• HLA-F
HLA-G β
2
-microglobulin binds with major and minor gene subunits to produce a heterodimer.
2-MHC class II: There are three major and two minor MHC class II proteins encoded by the 
HLA.
Major MHC class II:
1. HLA-DP
• α-chain encoded by HLA-DPA1 locus
• β-chain encoded by HLA-DPB1 locus
2. HLA-DQ
• α-chain encoded by HLA-DQA1 locus
• β-chain encoded by HLA-DQB1 locus
3. HLA-DR
• α-chain encoded by HLA-DRA locus
• β-chains (only three possible per person),
They are encoded by HLA-DRB1, DRB3, DRB4, and DRB5 loci.
The genes of the class II combine to form heterodimeric (αβ) protein receptors that are typi-
cally expressed on the surface of antigen-presenting cells.
Minor MHC class II:
• DM
• DO
They are used in the internal processing of antigens, loading the antigenic peptides generated 
from pathogens onto the HLA molecules of antigen-presenting cell [3, 4].
A person’s HLA complex is genetically inherited from their parents (50% from each parent), 
so you are more likely to have stronger matches with your siblings than with a random mem-
ber of the population; however, each pair of siblings still only has a 25% chance of matching 
perfectly. The likelihood of having a perfect match with someone unrelated to you is approxi-
mately 1 in 100,000. Thus, the closer the match between two people like identical twins, the 
less likely the recipient’s immune system will attack the donor’s cells (Figure 1) [5].
Human Leukocyte Antigen (HLA)2
1.2. Structure
1.2.1. MHC class I
MHC class I molecule structure is consisting from two heterodimer polypeptide chains, α and 
β
2
-microglobulin that linked together noncovalently by interaction of beta-2 microglobulin with 
α
3
 domain of alpha chain. The alpha chain is encoded by many genes which are highly polymor-
phic, while beta-2 microglobulin subunit is not polymorphic and encoded by genes called beta-2 
microglobulin gene. The other domain is α
3
 domain which is plasma membrane that interacts with 
CD8 receptor of T-cytotoxic lymphocytes. This α
3
-CD8 complex holds the MHC I molecule and the 
T-cell receptor (TCR) on the cell surface of the cytotoxic T cell binds its α
1
-α
2
 heterodimer and exam-
ines the foreign substance for antigenicity. The two domains, α
1
 and α
2
, fold to form a groove or 
basket for antigenic peptides to bind to it which consists of 8–10 amino acid in length (Figure 2) [6].
1.2.2. MHC class II
Class II molecules are also heterodimers in their structure, but consist of two homogenous 
peptides, an α and β polypeptide chain, both of which are encoded in the MHC. The alpha 
chain has two domes which are α
1
 and α
2
. Beta polypeptide chain has also two domains, β
1
 
Figure 1. HLA complex is found on chromosome 6 in humans [5].
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and β
2
. Every domain is encoded by a diverse exon gene, and other genes contain domains 
that encode different parts (leader sequences, transmembrane sequences, and cytoplasmic 
tail). The α
1
 and β
1
 regions of the chains form a membrane peptide binding domain, while the 
α
2
 and β
2
 regions form a membrane-proximal immunoglobulin-like domain. The groove or 
basket that binds the antigen or peptide is made up of two α-helix walls and β-sheet. Antigen-
binding groove of MHC class II molecules is open at both ends and the groove on class I 
molecules is closed at each end resulting in antigens that bind to MHC class II molecules 
longer about 15–24 amino acid residues long. These domains are also highly polymorphic 
(Figure 3) [7].
1.3. Function
The major histocompatibility complex is a highly polymorphic region in the human genome 
located on short arm of chromosome number 6 about 200 genes in the region and is directly 
involved with the immune system. This is due to balancing selection acting on many genes 
with recombination in the MHC region [8]. These genes are in association with nonimmu-
nologic genes like noncoding RNA genes, including expressed pseudogenes. MHC genes 
showed haplotype-specific linkage disequilibrium patterns contain the strongest cis- and 
trans-eQTLs/meQTLs in the genome and are called as a hot spot for disease associations. 
Figure 2. Structure of MHC class I.
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The haplotype HLA-DR/DQ is structurally most variable and shows the highest number of 
disease associations. Dependence on a single reference sequence is not easy. Thus, analysis of 
GWAS for the MHC region is needed. One of the several issues with expected GWAS analysis 
is that it does not address this additional layer of polymorphisms unique to the MHC region 
[9]. Genome-wide association studies (GWAS) demonstrated that MHC is an important area 
for disease association, for example, autoimmune diseases [10, 11]. This very high-variety 
and broad-linkage disequilibrium leads to difficulty in assessing the one that leads to dis-
ease development and associations. Genome mapping can be sequence in addition to MHC 
haplotype and genome reference [12–14]. Many methods are defined but they are expensive 
[15–18]. Thus, many alleles of HLA had an association with cancer, infection with microor-
ganisms in addition to its relation with transplant rejection.
1.4. Role of human leukocyte antigens (HLA) in transplantation
Human leukocyte antigens have an important role in graft rejection. One of the important 
squeal of mismatched graft is the development of donor-specific antibodies (DSA), which 
Figure 3. Structure of MHC class II.
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causes antibody-mediated rejection, graft loss, and repeat transplantation in addition to tissue 
typing. These DSA are induced by foreign epitopes present on the leukocytes mismatched 
with HLA antigens of the donor [19]. The presence of pretransplant DSAs in deceased donor 
transplantations is a risk marker for graft loss, whereas nondonor-specific anti-HLA antibod-
ies are not associated with a lower graft survival and sensitized patients with these antibodies 
directed against class I and II may be a risk marker for graft loss in the long term [20]. These 
antibodies develop through pregnancy, blood transfusions, or organ transplants. After viral 
infection or vaccination, antibodies produced may have the capacity to cross-react with HLA 
called heterologous immunity caused by T-cell alloreactivity or by bystander activation of 
dormant HLA-specific memory B cells [21].
1.5. Human leukocyte antigen and disease association
HLA had an important role in immunopathogenesis of many diseases. The strongest associa-
tion is HLA-B27 and ankylosing spondylitis. There is a long list of diseases associated with 
HLA. Bullous pemphigoid is the most common autoimmune blistering disease and is due to 
IgG recognition of two hemidesmosomal antigens, that is, BP230 (BP antigen 1) and BP180 
(BP antigen 2, collagen XVII). The role of HLA-DQB1*03:01 binding to the immunogenic por-
tion of BP180 provides a potential mechanism by which exposure to neuronal collagen BP180 
may lead to cutaneous disease. Patients who have allele HLA-DQB1*03:01 had an increased 
T-cell avidity to many epitopes like BP180-NC16a domain. Patients with Th1/Th2 imbalance, 
anergy is absent and T-cells are subsequently primed end in autoimmunity against the BP180-
NC16a domain and disease development [22]. Type 1 diabetes patients are more liable to 
develop celiac disease because these two diseases are associated with DQB1 *02:01 and DQB1 
*03:02 and the patients with coexisting T1 diabetes and celiac disease had an HLA profile 
more similar to T1D patients than CeD patients [23].
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